has been extensively characterized.7 In contrast, the more
recently discovered type II isomerase5,8 is a flavoprotein
whose activity requires divalent metal ion and NAD(P)H.9
Since the cofactor requirements for these two types of IPP
isomerase are so different, the type II isomerase may operate
by a mechanism distinct from that of the type I enzyme.10
Thus far, no mechanistic information about the type II
isomerase has been reported,11 presenting an exciting op-
portunity to initiate an investigation into this unusual enzyme.
In addition, the fact that the type II isomerase is essential
for some pathogens, including multidrug-resistant strains of
Staphylococcus aureus, Streptococci, and Enterococci, whereas
only type I isomerase is used in mammals, makes it an
attractive target for therapeutic agents.4b,5,8
by the yeast type I isomerase.14 However, the actual
stereospecificity of the C-2 deprotonation step of the Syn-
echocystis isomerase was not determined.
As part of our efforts to investigate the mechanism of type-
II isomerase, we have recently expressed the gene for the
type II isomerase from Staphylococcus aureus in Escherchia
coli according to the reported protocols8a and carried out a
stereochemical analysis of the reaction. Reported herein are
the results, which clearly indicate that the C-2 deprotonation
of IPP by the Staphylococcus isomerase is pro-R stereospe-
cific, suggesting an analogous stereochemical course as the
type I isomerase.
To facilitate the analysis, a new and convenient chemical
synthesis for preparing the stereospecifically labeled (S)-[2-
2H]IPP (5) and (R)-[2-2H]IPP (6) was developed.15 As
depicted in Scheme 2, the synthesis of (S)-[2-2H]IPP (5)
The reaction catalyzed by type I isomerase is a well-
established reversible 1,3-antarafacial process involving the
loss of the 2R-hydrogen of IPP and the addition of a solvent
hydrogen to C-4 of DMAPP.12 Although the mechanism of
type II isomerase remains elusive, the stereochemical course
of the deprotonation step for the type II enzyme from Bacillus
subtilis has been determined to be similar to that of type I
enzyme on the basis of an elegant, yet complex, labeling
study.13 In a separate report, prolonged incubation of IPP/
DMAPP with the type II isomerase from Synechocystis PCC
Scheme 2
2
6803 in H2O led to the incorporation of one deuterium at
C-2 and two deuteria at C-4 of IPP.14 Meanwhile, all three
hydrogens of the (E)-methyl group of DMAPP were ex-
changed with deuterium. Interestingly, under similar condi-
tions with the type I enzyme from yeast, only the protons at
C-1 of IPP and DMAPP remained unexchanged. It was thus
concluded that the reaction catalyzed by the Synechocystis
type II enzyme is more stereoselective than the one catalyzed
(4) (a) Rohdich, F.; Hecht, S.; Bacher, A. Pure Appl. Chem 2003, 75,
393-405. (b) Rohdich, F.; Bacher, A.; Eisenreich, W. Bioorg. Chem. 2004,
32, 292-308.
(5) Laupitz, R.; Hecht, S.; Amslinger, S.; Zepeck, F.; Kaiser, J.; Richter,
G.; Schramek, N.; Steinbacher, S.; Huber, R.; Arigoni, D.; Bacher, A.;
Eisenreich, W.; Rohdich, F. Eur. J. Biochem. 2004, 271, 2658-2669.
(6) (a) Rilling, H. C.; Bloch, K. J. Biol. Chem. 1959, 234, 1424-1432.
(b) Cornforth, J. W.; Popjak, G. Tetrahedron Lett. 1959, 19, 29-35.
(7) (a) Muehlbacher, M.; Poulter, C. D. Biochemistry 1988, 27, 7315-
7325. (b) Wouters, J.; Oudjama, Y.; Barkley, S. J.; Tricott, C.; Stalon, V.;
Droogmans, L.; Poulter, C. D. J. Biol. Chem. 2003, 278, 11903-11908.
(c) Wouters, J.; Oudjama, Y.; Stalon, V.; Droogmans, L.; Poulter, C. D.
Proteins: Struct., Funct., Bioinf. 2004, 54, 216-221.
(8) (a) Kaneda, K.; Kuzuyama, T.; Takagi, M.; Hayakawa, Y.; Seto, H.
Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 932-937. (b) Takagi, M.; Kaneda,
K.; Shimizu, T.; Hayakawa, Y.; Seto, H.; Kuzuyama, T. Biosci. Biotechnol.
Biochem. 2004, 68, 132-137. (c) Barkely, S. J.; Cornish, R. M.; Poulter,
C. D. J. Bacteriol. 2004, 186, 1811-1817. (d) Yamashita, S.; Hemmi, H.;
Ikeda, Y.; Nakayama, T.; Nishino, T. Eur. J. Biochem. 2004, 271, 1087-
1093.
(9) Under aerobic conditions, NADPH is required for enzyme activity.
However, if purified and assayed under strictly anaerobic conditions, the
addition of NADPH is no longer necessary.5
(10) The crystal structure of the type II isomerase from Bacillus subtilis
was recently determined; however, the substrate (1/2) binding site could
not be clearly defined (Steinbacher, S.; Kaiser, J.; Gerhardt, S.; Eisenreich,
W.; Huber, R.; Bacher, A.; Rohdich, F. J. Mol. Biol. 2003, 329, 973-
982).
begins with (2R)-trans-3-methyloxiranemethanol (8), which
was the product of Sharpless epoxidation of crotyl alcohol
(15) Compounds 5 and 6 were traditionally prepared enzymatically from
labeled mevalonic acid (see: Cornforth, J. W.; Cornforth, R. H.; Donninger,
C. Popjak, G. Proc. R. Soc. London, Ser. B 1965, 163, 492-514. Sagami,
H.; Ogura, K.; Seto, S. Biochemistry 1977, 16, 4616-4622). They could
also be chemically synthesized from dimethylally alcohol (Suga, T.; Ohta,
S.; Ohmoto, T. Chem. Soc., Perkin Trans. 1 1987, 2845-2848). A synthesis
of 6 starting from D-mannitol 1,2:5,6-bis-acetonide in high enantiomeric
excess was recently reported (Leyes, A. E.; Poulter, C. D. Org. Lett. 1999,
1, 1067-1070).
(11) Bornemann, S. Nat. Prod. Rep. 2002, 19, 761-772.
(12) (a) Clifford, K.; Cornforth, J. W.; Mallaby, R.; Philips, G. T. Chem.
Commun. 1971, 1599-1600. (b) Cornforth, J. W.; Clifford, K.; Mallaby,
R.; Philips, G. T. Proc. R. Soc. London, Ser. B. 1972, 182, 277-295.
(13) Laupitz, R.; Grawert, T.; Rieder, C.; Zepeck, F.; Bacher, A.; Arigoni,
D.; Rohdich, F.; Eisenreich, W. Chem. BiodiVersity 2004, 1, 1367-1376.
(14) Barkley, S. J.; Desai, S. B.; Poulter, C. D. Org. Lett. 2004, 6, 5019-
5021.
5678
Org. Lett., Vol. 7, No. 25, 2005